Computerized Cognitive Rehabilitation of Patients With Cognitive Deficits Due to the Human Immunodeficiency Virus
NCT ID: NCT06603727
Last Updated: 2024-09-19
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
NOT_YET_RECRUITING
Clinical Phase
NA
Total Enrollment
24 participants
Study Classification
INTERVENTIONAL
Study Start Date
2024-10-01
Study Completion Date
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
WHO: 24 participants with cognitive deficits due to a Human Immunodeficiency Virus (HIV) infection, able to engage in moderate physical activity.
WHY: The Human Immunodeficiency Virus is known to cause deficits in cognitive function, even under effective pharmacological viral load suppression. Cognitive dysfunction in patients with HIV is frequent and has a detrimental impact on their everyday personal and professional life. The purpose of this study is to evaluate two sets of computerized exercises combining cognitive and physical effort to see if they can improve executive function in patients with an HIV infection.
WHAT: Study participants first undergo cognitive and physical assessments. Additional questionnaires will assess mood, everyday life cognition, function and quality. This will be followed by a 6 week training period with 2 training sessions a week. The effect of the physical and cognitive training will be measured in a post-training evaluation session. Six months after completion of the training, the study will evaluate cognitive and physical abilities of participants to study long-term effects of the respective training program.
WHERE: Both the evaluation and the training sessions will be conducted on the premises of the Lausanne University Hospital (Rue du Bugnon 46, 1005 Lausanne, Switzerland)
WHY: The Human Immunodeficiency Virus is known to cause deficits in cognitive function, even under effective pharmacological viral load suppression. Cognitive dysfunction in patients with HIV is frequent and has a detrimental impact on their everyday personal and professional life. The purpose of this study is to evaluate two sets of computerized exercises combining cognitive and physical effort to see if they can improve executive function in patients with an HIV infection.
WHAT: Study participants first undergo cognitive and physical assessments. Additional questionnaires will assess mood, everyday life cognition, function and quality. This will be followed by a 6 week training period with 2 training sessions a week. The effect of the physical and cognitive training will be measured in a post-training evaluation session. Six months after completion of the training, the study will evaluate cognitive and physical abilities of participants to study long-term effects of the respective training program.
WHERE: Both the evaluation and the training sessions will be conducted on the premises of the Lausanne University Hospital (Rue du Bugnon 46, 1005 Lausanne, Switzerland)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CogStim, a Pilot Study : Cognitive Rehabilitation Management of HIV-1 Mild Cognitively Impaired Patients Controlled With Antiretroviral Therapy
NCT02343887
HIV
UNKNOWN
NA
Cognitive Training With and Without tDCS to Improve Cognition in HIV
NCT02647645
HIV
Mild Neurocognitive Disorder
TERMINATED
NA
Exergaming Revolution in Dementia
NCT06631742
Major Neurocognitive Disorder
Alzheimer Disease
Parkinson Disease
+2 more
RECRUITING
NA
Computerized Cognitive Rehabilitation in Ugandan Children With HIV
NCT00926003
HIV Infections
COMPLETED
NA
Computer Training and Transcranial Direct Current Stimulation for Cognition in HIV
NCT03440840
HIV-related Mild Neurocognitive Disorder
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is an exploratory Randomized Controlled Trial with the purpose of evaluating the potential of two sets of gamified cognitive and physical exercises in the neurorehabilitation of cognitive deficits due to an infection with the Human Immunodeficiency Virus (HIV).
Upon recruitment, eligible study participants (see 'Eligibility Criteria') receive a detailed oral and written description about the scientific background, aims and methods of the study. Additional information will be provided about potential benefits and risks associated with study participation, as well as about the voluntary nature of participation throughout the study. The participant's written informed consent is required for study enrollment.
After inclusion in the study, participants are randomized into one of two different training programs with equal chance of attribution and without possibility of choosing:
* Program 1 involves brain training and guided, light physical exercise games on a tablet device. The exercise involves movements such as reaching, stepping, and stretching. Warm-up and cool down sessions are mandated prior to and following the tasks.
* Program 2 involves gamified exercises displayed on a large screen. Participants use whole-body movements to complete the tasks. Tasks involve movements such as reaching, stepping, and jogging in place. These movements are tracked by a motion sensor. Warm-up and cool down sessions are mandated prior to and following the training sessions.
Independently of program attribution, participants engage in a pre-training assessment, a six-week training period, a post-training assessment and a 6-month-follow-up assessment.
Before the start of the training, participants are required to perform several cognitive and physical tests (including cyclo-ergospirometry) and fill out a number of questionnaires on subjective cognitive function, mood and quality of life. Additionally, an electroencephalography (EEG) will be performed to measure brain activity. The exercises, the questionnaires and the EEG serve as a baseline evaluation of cognitive, physical and neurophysiological function.
Following the first assessment, study participants engage in a six-week training period. In both programs, participants engage in two weekly trainings of ninety minutes duration each.
After completion of the training period, study participants engage in a post-training assessment to evaluate the effect of training on cognitive and physical performance. This session incorporates the same tasks and questionnaires as in the pre-training visit. An EEG will be used to characterize the training effects on dynamics of the underlying large-scale neuronal networks. The aim of the post-training assessment is to demonstrate immediate training effect of the two programs.
A final follow-up visit is scheduled 6 months after the completion of the last training session. The cognitive and physical testing together with the questionnaires and the EEG will be repeated to examine the long-term effects of the training programs.
Upon recruitment, eligible study participants (see 'Eligibility Criteria') receive a detailed oral and written description about the scientific background, aims and methods of the study. Additional information will be provided about potential benefits and risks associated with study participation, as well as about the voluntary nature of participation throughout the study. The participant's written informed consent is required for study enrollment.
After inclusion in the study, participants are randomized into one of two different training programs with equal chance of attribution and without possibility of choosing:
* Program 1 involves brain training and guided, light physical exercise games on a tablet device. The exercise involves movements such as reaching, stepping, and stretching. Warm-up and cool down sessions are mandated prior to and following the tasks.
* Program 2 involves gamified exercises displayed on a large screen. Participants use whole-body movements to complete the tasks. Tasks involve movements such as reaching, stepping, and jogging in place. These movements are tracked by a motion sensor. Warm-up and cool down sessions are mandated prior to and following the training sessions.
Independently of program attribution, participants engage in a pre-training assessment, a six-week training period, a post-training assessment and a 6-month-follow-up assessment.
Before the start of the training, participants are required to perform several cognitive and physical tests (including cyclo-ergospirometry) and fill out a number of questionnaires on subjective cognitive function, mood and quality of life. Additionally, an electroencephalography (EEG) will be performed to measure brain activity. The exercises, the questionnaires and the EEG serve as a baseline evaluation of cognitive, physical and neurophysiological function.
Following the first assessment, study participants engage in a six-week training period. In both programs, participants engage in two weekly trainings of ninety minutes duration each.
After completion of the training period, study participants engage in a post-training assessment to evaluate the effect of training on cognitive and physical performance. This session incorporates the same tasks and questionnaires as in the pre-training visit. An EEG will be used to characterize the training effects on dynamics of the underlying large-scale neuronal networks. The aim of the post-training assessment is to demonstrate immediate training effect of the two programs.
A final follow-up visit is scheduled 6 months after the completion of the last training session. The cognitive and physical testing together with the questionnaires and the EEG will be repeated to examine the long-term effects of the training programs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Human Immunodeficiency Virus
Cognitive Dysfunction
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Primary Study Purpose
TREATMENT
Blinding Strategy
TRIPLE
Participants
Investigators
Outcome Assessors
Masking will affect participants and study personnel, with exception to the personnel supervising the training programs.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Program 1
Computerized Gaming Rehabilitation Program 1
Group Type
EXPERIMENTAL
Computerized Gaming Rehabilitation Program 1
Intervention Type
DEVICE
Brain training games displayed on a large screen paired with physical exercise component. The program involves movements such as reaching, stepping, or stretching in place.
Program 2
Computerized Gaming Rehabilitation Program 2
Group Type
ACTIVE_COMPARATOR
Computerized Gaming Rehabilitation Program 2
Intervention Type
DEVICE
Brain training games displayed on a tablet device paired with physical exercise component. The program involves movements such as reaching, stepping, or stretching.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Computerized Gaming Rehabilitation Program 1
Brain training games displayed on a large screen paired with physical exercise component. The program involves movements such as reaching, stepping, or stretching in place.
Intervention Type
DEVICE
Computerized Gaming Rehabilitation Program 2
Brain training games displayed on a tablet device paired with physical exercise component. The program involves movements such as reaching, stepping, or stretching.
Intervention Type
DEVICE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
* Diagnosis of an HIV infection
* Undetectable HIV load in the serum (\<50 copies/mL) over the last 6 months prior to study inclusion.
* Z-score ≤ -1.0 in at least one of the three following tests:
* Color Trail Test (CTT) Flexibility Index
* subtest Code of the Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV)
* subtest Digit Span of the WAIS-IV
* Z-score ≤ -1.0 in at least one of the following tests:
* Symbol Digits Modalities Test (SDMT)
* Brief Visuospatial Memory Test Revised (BVMT-R)
* CTT Flexibility Index
* Stroop Color-Word interference test
* Diagnosis of an HIV infection
* Undetectable HIV load in the serum (\<50 copies/mL) over the last 6 months prior to study inclusion.
* Z-score ≤ -1.0 in at least one of the three following tests:
* Color Trail Test (CTT) Flexibility Index
* subtest Code of the Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV)
* subtest Digit Span of the WAIS-IV
* Z-score ≤ -1.0 in at least one of the following tests:
* Symbol Digits Modalities Test (SDMT)
* Brief Visuospatial Memory Test Revised (BVMT-R)
* CTT Flexibility Index
* Stroop Color-Word interference test
Exclusion Criteria
* Clinically defined cause for cognitive deficits other than HIV
* Diagnosis of severe depression according to a cut-off score of ≥ 27 of the Center for epidemiological studies - depression questionnaire (CES-D; Metral et al., 2020; Radloff, 1977)
* Diagnosis of HIV-associated dementia according to the Frascati Critera (Antinori et al., 2007)
* Current psychotic symptoms according to the Mini-International Neuropsychiatric Interview (M.I.N.I. - L, Sheehan et al., 1998) subscale of psychotic symptoms
* Antidepressive, anxiolytic or cART medication that has been changed over the last month
* Thoracic pain and/or heart palpitations at rest, during or following a physical effort (based on self-report)
* For patients without known and clinically stable cardio-vascular disease: abnormal rest electrocardiogram readings suggestive of second degree type Mobitz or third degree atrioventricular blocking, pathological repolarization (T-wave inversion, ST elevation, abnormal QT lengthening in at least two corresponding leads), or typical features of channelopathies
* Premature termination of maximal effort test due to cardiac problems
* Falls in the past 12 weeks as evaluated in the enrolment interview (Hopkins Falls Grading Scale, Grade \>1)
* High risk of falling according a cutoff score \> 15 sec in the Four Square Step Test (Dite \& Temple, 2002)
* Incapacity to discriminate colors or insufficient visual acuity that cannot be corrected
* Incapacity or unwillingness to provide informed consent
* Insufficient knowledge of French to understand and follow instructions
* Diagnosis of severe depression according to a cut-off score of ≥ 27 of the Center for epidemiological studies - depression questionnaire (CES-D; Metral et al., 2020; Radloff, 1977)
* Diagnosis of HIV-associated dementia according to the Frascati Critera (Antinori et al., 2007)
* Current psychotic symptoms according to the Mini-International Neuropsychiatric Interview (M.I.N.I. - L, Sheehan et al., 1998) subscale of psychotic symptoms
* Antidepressive, anxiolytic or cART medication that has been changed over the last month
* Thoracic pain and/or heart palpitations at rest, during or following a physical effort (based on self-report)
* For patients without known and clinically stable cardio-vascular disease: abnormal rest electrocardiogram readings suggestive of second degree type Mobitz or third degree atrioventricular blocking, pathological repolarization (T-wave inversion, ST elevation, abnormal QT lengthening in at least two corresponding leads), or typical features of channelopathies
* Premature termination of maximal effort test due to cardiac problems
* Falls in the past 12 weeks as evaluated in the enrolment interview (Hopkins Falls Grading Scale, Grade \>1)
* High risk of falling according a cutoff score \> 15 sec in the Four Square Step Test (Dite \& Temple, 2002)
* Incapacity to discriminate colors or insufficient visual acuity that cannot be corrected
* Incapacity or unwillingness to provide informed consent
* Insufficient knowledge of French to understand and follow instructions
Minimum Eligible Age
18 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Vaudois
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Arseny Sokolov, MD, PhD
Professor, MD
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arseny A. Sokolov, Prof MD PhD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
Etienne Sallard, PhD
Role: STUDY_CHAIR
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lausanne University Hospital (CHUV)
Lausanne, Canton of Vaud, Switzerland
Site Status
Countries
Review the countries where the study has at least one active or historical site.
Switzerland
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Smith, A. (1982). Symbol digit modalities test (SDMT) manual (revised) Western psychological services. Los Angeles.
Reference Type
BACKGROUND
Delis DC, Kramer JH, Kaplan E, Holdnack J. Reliability and validity of the Delis-Kaplan Executive Function System: an update. J Int Neuropsychol Soc. 2004 Mar;10(2):301-3. doi: 10.1017/S1355617704102191. No abstract available.
Reference Type
BACKGROUND
Benedict, R. H. (1997). Brief Visuospatial Memory Test-Revised (BVMT-R). Odessa, FL: Psychological Assessment Resources. In: Inc
Reference Type
BACKGROUND
Vallat-Azouvi C, Pradat-Diehl P, Azouvi P. The Working Memory Questionnaire: a scale to assess everyday life problems related to deficits of working memory in brain injured patients. Neuropsychol Rehabil. 2012;22(4):634-49. doi: 10.1080/09602011.2012.681110. Epub 2012 Apr 27.
Reference Type
BACKGROUND
Brandt, J. (1991). The hopkins verbal learning test: Development of a new memory test with six equivalent forms. Clinical Neuropsychologist, 5(2), 125-142.
Reference Type
BACKGROUND
Rieu D, Bachoud-Levi AC, Laurent A, Jurion E, Dalla Barba G. [French adaptation of the Hopkins Verbal Learning Test]. Rev Neurol (Paris). 2006 Jun;162(6-7):721-8. doi: 10.1016/s0035-3787(06)75069-x. French.
Reference Type
BACKGROUND
Greenberg, L., Kindschi, C., & Corman, C. (1996). TOVA clinical guide. Los Alamitos, CA: Universal Attention Disorders.
Reference Type
BACKGROUND
Kollins SH, DeLoss DJ, Canadas E, Lutz J, Findling RL, Keefe RSE, Epstein JN, Cutler AJ, Faraone SV. A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial. Lancet Digit Health. 2020 Apr;2(4):e168-e178. doi: 10.1016/S2589-7500(20)30017-0. Epub 2020 Feb 24.
Reference Type
BACKGROUND
Regard M, Strauss E, Knapp P. Children's production on verbal and non-verbal fluency tasks. Percept Mot Skills. 1982 Dec;55(3 Pt 1):839-44. doi: 10.2466/pms.1982.55.3.839. No abstract available.
Reference Type
BACKGROUND
Michel CM, Koenig T. EEG microstates as a tool for studying the temporal dynamics of whole-brain neuronal networks: A review. Neuroimage. 2018 Oct 15;180(Pt B):577-593. doi: 10.1016/j.neuroimage.2017.11.062. Epub 2017 Dec 2.
Reference Type
BACKGROUND
Spring JN, Tomescu MI, Barral J. A single-bout of Endurance Exercise Modulates EEG Microstates Temporal Features. Brain Topogr. 2017 Jul;30(4):461-472. doi: 10.1007/s10548-017-0570-2. Epub 2017 May 20.
Reference Type
BACKGROUND
Levett DZH, Jack S, Swart M, Carlisle J, Wilson J, Snowden C, Riley M, Danjoux G, Ward SA, Older P, Grocott MPW; Perioperative Exercise Testing and Training Society (POETTS). Perioperative cardiopulmonary exercise testing (CPET): consensus clinical guidelines on indications, organization, conduct, and physiological interpretation. Br J Anaesth. 2018 Mar;120(3):484-500. doi: 10.1016/j.bja.2017.10.020. Epub 2017 Nov 24.
Reference Type
BACKGROUND
Dite W, Temple VA. A clinical test of stepping and change of direction to identify multiple falling older adults. Arch Phys Med Rehabil. 2002 Nov;83(11):1566-71. doi: 10.1053/apmr.2002.35469.
Reference Type
BACKGROUND
Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test. Phys Ther. 2000 Sep;80(9):896-903.
Reference Type
BACKGROUND
Radloff, L. S. (1977). The CES-D Scale:A Self-Report Depression Scale for Research in the General Population. Applied Psychological Measurement, 1(3), 385-401.
Reference Type
BACKGROUND
Fuhrer, R. (1989). Fuhrer, R, Rouillon F. La version française de l'échelle CES-D (Center for Epidemiologic Studies-Depression Scale). Description et traduction de l'échelle d'autoévaluation Psychiatry and Psychobiology, 4, 163-166.
Reference Type
BACKGROUND
Spielberger, C. D. (1983). Manual for the State-Trait Anxiety Inventory STAI (form Y)(
Reference Type
BACKGROUND
Gauthier, J., & Bouchard, S. (1993). Adaptation canadienne-française de la forme révisée du State-Trait Anxiety Inventory de Spielberger. Canadian Journal of Behavioural Science/Revue canadienne des sciences du comportement, 25(4), 559.
Reference Type
BACKGROUND
Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res. 1997 Aug;6(6):481-93. doi: 10.1023/a:1018451930750.
Reference Type
BACKGROUND
Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982 Feb;21(1):1-16. doi: 10.1111/j.2044-8260.1982.tb01421.x.
Reference Type
BACKGROUND
Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F. Validity of a French version of the fatigue impact scale in multiple sclerosis. Mult Scler. 2007 Sep;13(8):1026-32. doi: 10.1177/1352458507077942.
Reference Type
BACKGROUND
Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci. 1994 Feb;21(1):9-14.
Reference Type
BACKGROUND
Radakovic R, Abrahams S. Developing a new apathy measurement scale: Dimensional Apathy Scale. Psychiatry Res. 2014 Nov 30;219(3):658-63. doi: 10.1016/j.psychres.2014.06.010. Epub 2014 Jun 19.
Reference Type
BACKGROUND
Khan R, Chatton A, Nallet A, Broers B, Thorens G, Achab-Arigo S, Poznyak V, Fleischmann A, Khazaal Y, Zullino D. Validation of the French version of the alcohol, smoking and substance involvement screening test (ASSIST). Eur Addict Res. 2011;17(4):190-7. doi: 10.1159/000326073. Epub 2011 Apr 14.
Reference Type
BACKGROUND
Metral M, Darling K, Locatelli I, Nadin I, Santos G, Brugger P, Kovari H, Cusini A, Gutbrod K, Tarr PE, Calmy A, Lecompte TD, Assal F, Monsch A, Kunze U, Stoeckle M, Schwind M, Schmid P, Pignatti R, Di Benedetto C, Du Pasquier R, Cavassini M; NAMACO study group; Swiss HIV Cohort Study. The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile. HIV Med. 2020 Jan;21(1):30-42. doi: 10.1111/hiv.12795. Epub 2019 Oct 7.
Reference Type
BACKGROUND
Brooke, J., SUS: A 'Quick and Dirty' Usability Scale. 1996.
Reference Type
BACKGROUND
Boot WR, Champion M, Blakely DP, Wright T, Souders DJ, Charness N. Video games as a means to reduce age-related cognitive decline: attitudes, compliance, and effectiveness. Front Psychol. 2013 Feb 1;4:31. doi: 10.3389/fpsyg.2013.00031. eCollection 2013.
Reference Type
BACKGROUND
Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007 Oct 30;69(18):1789-99. doi: 10.1212/01.WNL.0000287431.88658.8b. Epub 2007 Oct 3.
Reference Type
BACKGROUND
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57.
Reference Type
BACKGROUND
Maj M, D'Elia L, Satz P, Janssen R, Zaudig M, Uchiyama C, Starace F, Galderisi S, Chervinsky A; World Health Organization, Division of Mental Health/Global Programme on AIDS. Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study. Arch Clin Neuropsychol. 1993 Mar;8(2):123-35.
Reference Type
BACKGROUND
Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gomez JM, Heitmann BL, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, Schols AM, Pichard C; Composition of the ESPEN Working Group. Bioelectrical impedance analysis--part I: review of principles and methods. Clin Nutr. 2004 Oct;23(5):1226-43. doi: 10.1016/j.clnu.2004.06.004.
Reference Type
BACKGROUND
Sternberg S. High-speed scanning in human memory. Science. 1966 Aug 5;153(3736):652-4. doi: 10.1126/science.153.3736.652.
Reference Type
BACKGROUND
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUV-DNC-CCT-HIV-2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Cognitive Training for the Remediation of Functional Brain Health in HIV
NCT02571504
COMPLETED
NA
Computerized Cognitive Training in MS
NCT03737825
COMPLETED
NA
Cognitive Remediation for HIV-associated Neurocognitive Dysfunction
NCT02671526
COMPLETED
NA
Cognitive Motion-Based Videogames Exploratory Study in Acquired Brain Injury
NCT02753244
UNKNOWN
NA
Cognitive Training in Parkinson's Disease
NCT01393353
COMPLETED
NA
PC-Based Cognitive Rehabilitation for Traumatic Brain Injury (TBI)
NCT00927576
COMPLETED
B.R.A.I.N in People Living With HIV Study
NCT06466642
RECRUITING
NA
Feasibility and Effectiveness of a Home-based Motor-cognitive Training Program in Older Adults
NCT05751551
COMPLETED
NA
Cognitive Rehabilitation Therapy for COVID-19
NCT06086379
ENROLLING_BY_INVITATION
NA
Virtual Reality Rehabilitation for Cognitive, Emotional, and Motor Recovery in Neurological Disorders
NCT06838975
ACTIVE_NOT_RECRUITING
NA
Tablet-based Cognitive Training
NCT04452864
COMPLETED
NA
Impact of Video-based Information Regarding Functional Rehabilitation
NCT04296981
COMPLETED
NA
Tablet-based Application for Cognitive Therapy
NCT06462703
RECRUITING
NA
Cognitive Rehabilitation for People With Multiple Sclerosis
NCT06179134
NOT_YET_RECRUITING
NA
Telerehabilitation for Cognitive Impairment Following Acquired Brain Injury
NCT03933475
COMPLETED
NA
Neurocognitive Rehabilitation Using Virtual Reality
NCT04017091
COMPLETED
NA
Tablet-based Interactive Games in Elderly With Cognitive Impairment and Persons With Intellectual Disability
NCT05822596
COMPLETED
NA
Health Related Quality of Life Effects of Off-the-shelf Computer Gaming in Alzheimer and Related Disorders Populations
NCT01416012
TERMINATED
NA
Neurodevelopmental Assessment of Children in Uganda and Malawi Using a Software Package
NCT03878147
COMPLETED
NA
Non-randomized Clinical Trial on Cognitive Stimulation With Virtual Reality in Patients With Mild Cognitive Impairment
NCT06977815
RECRUITING
NA
Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the Community
NCT06608797
RECRUITING
NA
Cognitive Remediation to Improve Mobility in Sedentary Seniors
NCT02567227
COMPLETED
NA
SCGs as a Proxy for Determining the Cognitive Status of Older Adults
NCT06367231
COMPLETED
Cognitive Rehabilitation of Deficits in Patients With Multiple Sclerosis
NCT06964581
RECRUITING
NA